Today 13cents , dont be the last person to throw. People buy at 40cents already lost 70% of their capital. Protect your capital, live to fight another day. Stay here and die standing.. just my advice ...

@Vodka move on la.. dont lose ur opportunity cost by get stuck here.
30/09/2020 4:21 PM

correct, many those that cutloss earlier are making big bucks in other strong fundamental counters

To those naysayers if you dont believe in Karma, look at TeamRocket. He had been misleading alot of people to lose money and cause many suffering to other investors and now whichever counter he goes will continue go down . Today you may feel good writing nonsense to cause people panic and lose money but one day your karma will come back to you

Supermax can breakout to RM11 at any time thats about %30 upsides and test new high in October

So all these countries that has been producing vaccine has been supplying their vaccine to other countries. Seems like they dont trust its own effectiveness , and countries like Indonesia,India,Philippine that has been volunteering to use this early vaccine to use for their citizen has yet to show sign of the virus getting under control

Tomorrow will limit up, Supermax RM11.00 tomorrow . Last chance to buy today to enjoy 30% upside

if TopGlove can close above RM9.20 today , we might be seeing Topglove surpassing Maybank by this month may close higher than RM10 by 30th september

https://www.youtube.com/watch?v=wWbEa7qPbpw

The UN secretary-general told world leaders they have failed to fight the coronavirus - preferring to trade words rather than unite in the face of the pandemic.
Antonio Guterres was speaking as representatives from the United States and China were involved in angry exchanges at a session of the Security Council over who was responsible.
Al Jazeera's Mike Hanna reports from New York, US.

https://www.youtube.com/watch?v=wWbEa7qPbpw

The UN secretary-general told world leaders they have failed to fight the coronavirus - preferring to trade words rather than unite in the face of the pandemic.
Antonio Guterres was speaking as representatives from the United States and China were involved in angry exchanges at a session of the Security Council over who was responsible.
Al Jazeera's Mike Hanna reports from New York, US.

Malaysia has been hit with over 100 case for almost a week now, we might hit 200-300 cases a day in 2 weeks time. there is a high possibility that we might go back into more restricted MCO and with that there might be an extended Moratorium. All this will have impact on Genting,Banks,Construction,Developer,Oil & Gas counters. There is no other better place to invest than healthcare especially glove counters

Malaysia has been hit with over 100 case for almost a week now, we might hit 200-300 cases a day in 2 weeks time. there is a high possibility that we might go back into more restricted MCO and with that there might be an extended Moratorium. All this will have impact on Genting,Banks,Construction,Developer,Oil & Gas counters. There is no other better place to invest than healthcare especially glove counters

Malaysia has been hit with over 100 case for almost a week now, we might hit 200-300 cases a day in 2 weeks time. there is a high possibility that we might go back into more restricted MCO and with that there might be an extended Moratorium. All this will have impact on Genting,Banks,Construction,Developer,Oil & Gas counters. There is no other better place to invest than healthcare especially glove counters

@ThePowerOfGlove HLT PAT did RM4.8mil profit in last quarter , and with 1billion capacity if next quarter they can make almost RM10mil i believe anything below RM2 is still ok but be cautious HLT PE Ratio is insanely high, its current price already priced in for good result in next few quarters its earning per share is also less than 1cent. but in my opinion HLT has big potential to grow their production line to increase their capacity and with only 1.7b market cap they can grow much bigger if a large company can buy them over... if glove shortage continue in the next few years (2024-2025) we might be able to see HLT able to increase their capacity much faster than its competitor.
Just be wary the price fluctuation of HLT in short term is not for the faint hearted... I would suggest to buy on price weakness sell on extreme strong price and later on after glove mania is over HLT may have huge correction that would be the best time to buy in for long term investment

@thepowerofglove i went in at rm2.20 during the major correction as i felt that careplus below rm4 is too irresistible. Went in again at rm2.70 , been giving good gains and more to come. With 4bil glove capacity on OBM model and 8bil glove capacity by 2021 i have full faith that careplus can hit rm9, thats 300% upside or 3 times of its current value (comfort oem 5.7b Capacity by 2021, ruberex oem 2b Capacity since june 2020) . You can see how undervalued Careplus is and how much potential it has. I dare to say 2022 careplus profit after tax can catch up to Kossan With 30b capacity just like Supermax with only 24b capacity yet double Harta’s profit with almost 40b capacity . This is the power of OBM

Comfort (OEM) RM3.82 current capacity 5,4billion, 2021 capacity 5.9billion Current PAT 42.7mil
Ruberex (OEM) RM5.37 current capacity 3billion Current PAT 22.9mil
Careplus (OBM) RM3.15 current capacity 4billion, 2021 capacity 8billion PAT 36.2mil

Why do I think Careplus will have most upside potential?
1) its OBM just like Supermax so it has bigger potential to have bigger PAT in the next quarter.
2) Capacity will be doubled by 2021 , with high margin and increasing ASP can you imagine in 2021 Careplus may even reach RM100mil PAT per quarter!
3) Next QR on October if above RM50mil (which i believe with its OBM model can easily achieved) the share price might go all the way to rm9 thats almost 300% or 3 times the current share price. Assuming you own 100,000 shares of Careplus valued at RM315,000 today. It might grow to as high as RM900,000 next month and even higher next year. Remember how Supermax grow from RM1.60 to RM24.44?

From the past Careplus history , when careplus is on a good rally it would limit up the next day...

Careplus Limit up 25/9/2020

RM4.10

@DickyMe how can it drop to RM4 when there is so much SBB and EPF in it? its just impossible unless next 2 quarters Topglove 2 more bonus issue and that would mean the value of topglove already doubled current value

@gloveisdiamond could be EPF collecting?

With EPF coming in , if IB try to do anything funny just wait for SC to knock at their door

Supermax next quarter profit margin will be higher than 70% ....

freetospeak EPF mayb also secretly buying supermax i think...lol...dun wan to buy above 5% like topglove. Then one day u might c they suddenly appear as majority shareholder.
24/09/2020 8:50 AM

I also strongly believe this, we will know for sure in time. EPF has alot of money at their disposal and at the moment i dont see any other counter they put their money in bursa

Comfort is currently the most undervalued glove stock, rm3.60 with PE27 lowest PE ratio. With its almost 50mil PAT its easily worth RM 8-9

Careplus OBM just like Supermax, it has potential to grow to rm8 if next PAT can exceed RM50mil

Next quarter if HLT can convincingly report PAT more than rm20mil like Careplus we might see HLT share price breakout to RM4?

Comfort current has the lowest P/E ratio among all the glove counters at 27, seriously undervalued and most likely will go up highest during breakout. Can climb as high as 5 there is more than 50% upside potential

https://edition.cnn.com/world/live-news/coronavirus-pandemic-09-22-20-intl/h_d87943489d99be3975c8407911232cb9

Updated 1:00 p.m. ET, September 22, 2020

Vaccinating whole world against Covid-19 won't happen until 2024, manufacturer says

India's Serum Institute, the world's largest vaccine manufacturer, says it will take until 2024 for the whole world to get vaccinated against the novel coronavirus.

Poonawalla said some of the challenges of getting vaccines from the point of research and approval to administering them to patients include scaling up manufacturing of the vaccines and raising billions of dollars to fund procurement of the necessary doses.

He said administering the vaccines in certain complex geographies and countries is also a challenge.

The Serum Institute of India is working with five Covid-19 vaccine developers and is gearing up to make hundreds of millions of doses. But even then, the vaccine supply will only go so far in the short term.

Take India, for example, with a population of 1.4 billion.

"By July, August next year, even if we were to produce 400 million does, they're still going to struggle to vaccinate everyone using those doses,” Poonawalla said.

https://edition.cnn.com/world/live-news/coronavirus-pandemic-09-22-20-intl/h_d87943489d99be3975c8407911232cb9

Updated 1:00 p.m. ET, September 22, 2020

Vaccinating whole world against Covid-19 won't happen until 2024, manufacturer says

India's Serum Institute, the world's largest vaccine manufacturer, says it will take until 2024 for the whole world to get vaccinated against the novel coronavirus.

Poonawalla said some of the challenges of getting vaccines from the point of research and approval to administering them to patients include scaling up manufacturing of the vaccines and raising billions of dollars to fund procurement of the necessary doses.

He said administering the vaccines in certain complex geographies and countries is also a challenge.

The Serum Institute of India is working with five Covid-19 vaccine developers and is gearing up to make hundreds of millions of doses. But even then, the vaccine supply will only go so far in the short term.

Take India, for example, with a population of 1.4 billion.

"By July, August next year, even if we were to produce 400 million does, they're still going to struggle to vaccinate everyone using those doses,” Poonawalla said.

Thursday, 17 September 2020 LIMIT UP
Top Glove RM8.43 -> RM10.96
Supermax RM8.37 -> RM10.88
Careplus RM RM3.24 -> RM4.21
HLT RM1.63 -> RM2.12

Thursday, 17 September 2020 LIMIT UP
Top Glove RM8.43 -> RM10.96
Supermax RM8.37 -> RM10.88
Careplus RM RM3.24 -> RM4.21
HLT RM1.63 -> RM2.12

Thursday, 17 September 2020 LIMIT UP
Top Glove RM8.43 -> RM10.96
Supermax RM8.37 -> RM10.88
Careplus RM RM3.24 -> RM4.21
HLT RM1.63 -> RM2.12

@cksam why so desperate everyday trying to create fear to fool uninformed investors to sell glove counters? for someone who is not gaining anything you sure spend alot of times to see other people lose money. Something is wrong with you one day karma will come back to you

Thursday, 17 September 2020 LIMIT UP
Top Glove RM8.43 -> RM10.96
Supermax RM8.37 -> RM10.88
Careplus RM RM3.24 -> RM4.21
HLT RM1.63 -> RM2.12

Thursday, 17 September 2020 LIMIT UP
Top Glove RM8.43 -> RM10.96
Supermax RM8.37 -> RM10.88
Careplus RM RM3.24 -> RM4.21
HLT RM1.63 -> RM2.12

Thursday, 17 September 2020 LIMIT UP
Top Glove RM8.43 -> RM10.96
Supermax RM8.37 -> RM10.88
Careplus RM RM3.24 -> RM4.21
HLT RM1.63 -> RM2.12

Thursday, 17 September 2020 LIMIT UP
Top Glove RM8.43 -> RM10.96
Supermax RM8.37 -> RM10.88
Careplus RM RM3.24 -> RM4.21
HLT RM1.63 -> RM2.12

Careplus Limit UP price RM4.24

Just profit taking from contra players that bought on Friday T+2. Once Friday contra player cleared will go back green as most will start buying back again

@liquidity its natural, just contra players that bought on Friday. They sell now to clear T+2, and will buy back

normal profit taking nothing to worry, just opportunity for those looking for bargain hunting. Harta and Kossan has less contra, so didt affect much

US-based Allied Market Research estimates that the global disposable gloves market amounted to US$6.8 billion in 2019, and is expected to nearly triple to US$18.8 billion by 2027.

https://www.nst.com.my/world/world/2020/09/622064/malaysias-glove-makers-struggle-meet-booming

--------------------------------------------
currently Topglove hold 26% world market share, if you take 26% of US$6.8billion its equivalent to RM7.3billion. True enough Topglove revenue for the year 2019 is about RM6bil+

and according to Tan Sri, by 2020 Topglove would have 30% world market share. Assuming that Topglove would grow to 35% of world market share by 2027 that would make Topglove Revenue very close to RM27billion by 2027 . Which means even post covid Topglove will still have increased in Revenue and Profit therefore their share price will not go back to pre-covid level ever but instead it will continuously go up to new high

Those who bought 1000 shares of Topglove in 2001 at RM2700 would have become RM1.02mil by today share price. Since 19 years Topglove share price has went up over 10000%

Tan Sri Lim is an ambitious and visionary man, if you believe in his vision to grow Topglove into fortune 500 country you must believe that today price is still very very cheap. Despite Topglove share price has went up record high when has Tan Sri ever sold his shares?

US-based Allied Market Research estimates that the global disposable gloves market amounted to US$6.8 billion in 2019, and is expected to nearly triple to US$18.8 billion by 2027.

https://www.nst.com.my/world/world/2020/09/622064/malaysias-glove-makers-struggle-meet-booming

-------------------------

currently topglove hold 26% world market share, if you take 26% of US$6.8billion its equivalent to RM7.3billion. True enough Topglove revenue for the year 2019 is about RM6bil+

and according to Tan Sri, by 2020 Topglove would have 30% world market share. Assuming that Topglove would grow to 35% of world market share by 2027 that would make Topglove Revenue very close to RM27billion by 2027 . Which means even post covid Topglove will still have increased in Revenue and Profit therefore their share price will not go back to pre-covid level ever but instead it will continuously go up to new high

Those who bought 1000 shares of Topglove in 2001 at RM2700 would have become RM1.02mil by today share price. Since 19 years Topglove share price has went up over 10000%

Tan Sri Lim is an ambitious and visionary man, if you believe in his vision to grow Topglove into fortune 500 country you must believe that today price is still very very cheap. Despite Topglove share price has went up record high when has Tan Sri ever sold his shares?

HLT already freeze tomorrow, alot of attention will be on Careplus tomorrow

Tomorrow Careplus Limit UP price RM4.24

Limit up
1. TOPGLOVE - RM10.08
2. SUPERMAX - RM9.75
3 RUBBEREX - RM6.86
4. COMFORT - RM4.77
5. CAREPLUS - RM3.26
6. HLT - RM1.64
7. ADVENTA - RM2.85

Limit up
1. TOPGLOVE - RM10.08
2. SUPERMAX - RM9.75
3 RUBBEREX - RM6.86
4. COMFORT - RM4.77
5. CAREPLUS - RM3.26
6. HLT - RM1.64
7. ADVENTA - RM2.85

Limit up
1. TOPGLOVE - RM10.08
2. SUPERMAX - RM9.75
3 RUBBEREX - RM6.86
4. COMFORT - RM4.77
5. CAREPLUS - RM3.26
6. HLT - RM1.64
7. ADVENTA - RM2.85

Limit up
1. TOPGLOVE - RM10.08
2. SUPERMAX - RM9.75
3 RUBBEREX - RM6.86
4. COMFORT - RM4.77
5. CAREPLUS - RM3.26
6. HLT - RM1.64
7. ADVENTA - RM2.85

Thats why doctors,scientists and virologist has warned the risk of rushing Vaccine! it might hurt public confidence of the vaccine efficiency and risk, therefore many will refuse to get vaccine shot when a working one released in the future...

China SINOVAC Vaccine Clinical trial got infected

China Vaccine Just Propangada PLACEBO?

https://www.aa.com.tr/en/asia-pacific/indonesia-chinese-vaccine-trial-volunteer-gets-virus/1970177

Indonesia: Chinese vaccine trial volunteer gets virus
Whether volunteer received potential vaccine or placebo remains unknown, says clinical trial team leader
Nicky Aulia Widadio |
11.09.2020

JAKARTA

A clinical trial volunteer for a Chinese COVID-19 vaccine candidate in Indonesia tested positive for the virus, said the trial team leader on Friday.

The vaccine is developed by a Chinese company, Sinovac Biotech, and imported to the country by the state-owned Bio Farma.

Kusnandi Rusmil, the head of the trial and research team from Padjadjaran University, said in a statement that the infected volunteer has been put in isolation under strict supervision.

"After nine days, the volunteer’s condition seems to be good," said Rusmil, without specifying the volunteer’s gender.

He said the volunteer, after receiving the first injection for the trial, traveled out of town.

“The volunteer was declared healthy upon returning from the trip and then received the second injection,” said Rusmil.

However, he added, due to their travel history, the volunteer was required to take COVID-19 test by the local health authority and tested positive for the virus.

Rusmil said he was unable to confirm whether the volunteer was injected with a potential vaccine or a placebo.

“As we conduct the trials under blind observer principle, we cannot identify who gets the vaccine and who gets the placebo,” he added.

Volunteers who were injected with placebo would be compared to those who were injected with the potential vaccine to determine its capability to build immunity.

Rusmil went on to say that the volunteers’ immunity against the virus would be formed after the second injection.

"Clinical trial volunteers will still have their health monitored for six months after the last injection," he said.

The team is conducting Phase 3 of the clinical trials, which started in early August to last six months.

At least 450 volunteers have been injected with a potential vaccine or placebo.

* Writing by Rhany Chairunissa Rufinaldo from Anadolu Agency's Indonesian language services in Jakarta.

----------------------

Trial volunteer injected with Sinovac , infected with Covid. 2 Questions.

1) is the vaccine injection just mere "placebo" to make you feel good but does not prevent u from getting infected?

2) or did the test subject get infected from the vaccine itself?

either way both isnt good it means the so called china vaccine is not effective at all

Person injected with Sinovac , infected with Covid. 2 Questions.

1) is the vaccine injection just mere "placebo" to make you feel good but does not prevent u from getting infected?

2) or did the test subject get infected from the vaccine itself?

either way both isnt good